The global costs of schizophrenia.

The global costs of schizophrenia.

Schizophrenia is a chronic disease associated with a significant and long-lasting health, social, and financial burden, not only for patients but also for families, other caregivers, and the wider society. Many national and local studies have sought to estimate the societal burden of the illness--or...

書目詳細資料
Main Authors:	Knapp, M, Mangalore, R, Simon, J
格式:	Journal article
語言:	English
出版:	2004

相似書籍

The cost of schizophrenia in Japan
由: Sado M, et al.
出版: (2013-05-01)

The global prevalence of schizophrenia.
由: Dinesh Bhugra
出版: (2005-05-01)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
由: Correll Christoph U, et al.
出版: (2008-04-01)

Costs and efficacy ofolanzapine and risperidone in schizophrenia
由: Vittorio Mapelli
出版: (2007-06-01)

The cost of relapse and the predictors of relapse in the treatment of schizophrenia
由: Slade Eric P, et al.
出版: (2010-01-01)

Cost of schizophrenia: direct costs and use of resources in the State of São Paulo
由: Leitão Raquel Jales, et al.
出版: (2006-01-01)

Selective impairment of global motion integration, but not global form detection, in schizophrenia and bipolar affective disorder
由: Daniel Bennett, et al.
出版: (2016-03-01)

Cost-effectiveness of Positive Memory Training (PoMeT) for the treatment of depression in schizophrenia
由: Simon, J, et al.
出版: (2022)

Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia
由: Vos Theo, et al.
出版: (2011-05-01)

The global fight against the stigma of schizophrenia.
由: Nadia Kadri, et al.
出版: (2005-07-01)

The global fight against the stigma of schizophrenia.
出版: (2005-07-01)

Local and global limits on visual processing in schizophrenia.
由: Marc S Tibber, et al.
出版: (2015-01-01)

Cost-effectiveness of clozapine to prevent suicide in schizophrenia: Interim results
由: Dakin, H, et al.
出版: (2003)

Correction: Local and Global Limits on Visual Processing in Schizophrenia.
由: Marc S Tibber, et al.
出版: (2019-01-01)

Physical health examination in outpatients with schizophrenia: the cost effectiveness of laboratory screening tests
由: Saana Eskelinen, et al.
出版: (2020-12-01)

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China
由: Rui Luo, et al.
出版: (2023-08-01)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
由: Ali Abdall-Razak, et al.
出版: (2019-09-01)

Costs of Globalization
由: Farrukh Nawaz Kayani, et al.
出版: (2012-12-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
由: Dutina Aleksandra, et al.
出版: (2019-01-01)

Global research in schizophrenia and serotonin: a bibliometric analysis
由: Gustavo Canul-Medina, et al.
出版: (2024-08-01)

Correction: Local and global limits on visual processing in schizophrenia.
由: PLOS ONE Staff
出版: (2015-01-01)

Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia
由: Faries Douglas E, et al.
出版: (2010-01-01)

The cost-of-illness trend of schizophrenia in South Korea from 2006 to 2016.
由: Minkyung Jo, et al.
出版: (2020-01-01)

Schizophrenia treatment in the developing world: an interregional and multinational cost-effectiveness analysis
由: Dan Chisholm, et al.
出版: (2008-07-01)

Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
由: Jia Liu, et al.
出版: (2022-09-01)

Effects of medication adherence on hospitalizations and healthcare costs in patients with schizophrenia in Thailand
由: Piyameth Dilokthornsakul, et al.
出版: (2016-03-01)

Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs
由: Giorgio Mariani, et al.
出版: (2006-09-01)

Evidence for Distinguishable Treatment Costs among Paranoid Schizophrenia and Schizoaffective Disorder.
由: Dusan Hirjak, et al.
出版: (2016-01-01)

Corrigendum: Global research in schizophrenia and serotonin: a bibliometric analysis
由: Gustavo Canul-Medina, et al.
出版: (2024-09-01)

Global economic burden of schizophrenia: response to authors’ reply
由: Neil AL, et al.
出版: (2017-02-01)

Functional graph alterations in schizophrenia: a result from a global anatomic decoupling?
由: Cabral, J, et al.
出版: (2012)

Schizophrenia /
由: Hirsch, Steven R., et al.
出版: (2003)

Still Regarding Schizophrenia, Secondary Schizophrenia, Pseudo-Schizophrenia, and Schizophrenia-Like Psychosis
由: João Gama Marques
出版: (2022-06-01)

Cost analysis of lurasidone for the treatment of schizophrenia in adolescents and adults within the United Kingdom
由: Amy Dymond, et al.
出版: (2022-08-01)

Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China
由: Jia Liu, et al.
出版: (2022-11-01)

Cost-effectiveness analysis of current treatment of individuals with acute exacerbation of schizophrenia in Bulgaria
由: Desislava Ignatova, et al.
出版: (2019-01-01)

Costs of treating patients with schizophrenia who have illness-related crisis events
由: Peng Xiaomei, et al.
出版: (2008-08-01)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
由: O&#39;Day K, et al.
出版: (2013-09-01)

Schizophrenia in the Netherlands: Continuity of Care with Better Quality of Care for Less Medical Costs.
由: Arnold van der Lee, et al.
出版: (2016-01-01)

Study Protocol: Global Research Initiative on the Neurophysiology of Schizophrenia (GRINS) project
由: Jun Wang, et al.
出版: (2024-06-01)